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Abstract
Background: Traumatic brain injury (TBI) is a leading cause of death and disability world-wide.
The ability to accurately predict patient outcome after TBI has an important role in clinical practice
and research. Prognostic models are statistical models that combine two or more items of patient
data to predict clinical outcome. They may improve predictions in TBI patients. Multiple prognostic
models for TBI have accumulated for decades but none of them is widely used in clinical practice.
The objective of this systematic review is to critically assess existing prognostic models for TBI
Methods: Studies that combine at least two variables to predict any outcome in patients with TBI
were searched in PUBMED and EMBASE. Two reviewers independently examined titles, abstracts
and assessed whether each met the pre-defined inclusion criteria.
Results: A total of 53 reports including 102 models were identified. Almost half (47%) were
derived from adult patients. Three quarters of the models included less than 500 patients. Most of
the models (93%) were from high income countries populations. Logistic regression was the most
common analytical strategy to derived models (47%). In relation to the quality of the derivation
models (n:66), only 15% reported less than 10% pf loss to follow-up, 68% did not justify the
rationale to include the predictors, 11% conducted an external validation and only 19% of the
logistic models presented the results in a clinically user-friendly way
Conclusion: Prognostic models are frequently published but they are developed from small
samples of patients, their methodological quality is poor and they are rarely validated on external
populations. Furthermore, they are not clinically practical as they are not presented to physicians
in a user-friendly way. Finally because only a few are developed using populations from low and
middle income countries, where most of trauma occurs, the generalizability to these setting is
limited.
Background
Traumatic brain injury (TBI) is a leading cause of death
and disability worldwide. Every year, an estimated 1.5
million people die and hundreds of millions require
emergency treatment after a TBI. Fatality rates and disabil-
ity rates vary depending on the severity and mechanisms
of the TBI but unfavourable outcomes (death, vegetative
state and severe disability) following TBI can be higher
than 20%[1,2].
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Physicians routinely make diagnostic and therapeutic
decisions based on the patient's prognosis. Furthermore,
prognostic information is also important in the counsel-
ling of patients and relatives in this critical scenario. Nev-
ertheless in general, physicians believe that their
predictions are inaccurate. A survey of doctors about prog-
nosis in TBI found that only 37% thought that they cur-
rently assess prognosis accurately[3].
Prognostic models are statistical models that combine two
or more items of patient data to predict clinical outcome.
They may improve predictions in TBI patients. Some stud-
ies have shown that they are more reliable than what doc-
tors can foretell [4]. A study conducted with TBI patients
demonstrated that the introduction of a computer-based
outcome prediction influenced patient management, with
a higher use of resources in those patients with better
prognosis [5].
Prognostic models could also be used in the design and
analysis of Randomized Controlled Trials (RCTs). RCTs in
TBI patients face many difficulties. Trauma is one of the
most neglected research topics worldwide with a paucity
of resources invested in RCTs [6]. Furthermore, unfamili-
arity with issues of informed consent in unconscious
patients pose further obstacles in this clinical setting [7].
Because of these barriers RCT in TBI are generally under-
powered. A review of published RCTs in this area found
that the average size was 82 participants per trial and no
trial was large enough to detect reliably a 5% absolute
reduction in risk [8]. Prognostic models have been pro-
posed as a way to improve the power in TBI and stroke
clinical trials [9,10]. With one such approach TBI patients'
outcomes are defined taking account their baseline prog-
nosis, instead of using the usual Glasgow Outcome Scale
dichotomized in favourable or unfavourable.
Prognostic models can also assist in clinical audit by
allowing adjustment for case-mix [11,12].
Multiple prognostic models for TBI have accumulated for
decades but none of them is widely used in clinical prac-
tice. For a prognostic model to be clinically useful it
should fulfil two requirements: it must be clinically valid
and methodologically valid [13]. Systematic reviews of
prognostic models in different areas of medical care have
shown that models often fail in these two aspects [14,15].
Previous reviews of prognostic studies in TBI have only
focused on individual predictors or have been restricted to
prognostic models of some type of traumatic brain injury
or outcome. So far, there has not been any comprehensive
systematic review of prognostic models in traumatic brain
injury [16,17]. It has then become increasingly important
to identify and evaluate prognostic models in TBI
patients.
Objective
Our objectives were
(a) identify prognostic models in traumatic brain injury
(b) describe their characteristics
(c) investigate their quality and
(d) described the models that were validated in an exter-
nal population.
Methods
Type of studies
We included studies that gave an overall prognostic esti-
mation combining the predictive information from at
least two variables. Studies could develop new prognostic
models (derivation studies) or evaluate previous ones
(validation studies). Studies conducted prior to 1990 were
excluded because patient management and diagnostic
techniques may have changed since this time. Studies that
investigate more than one variable but do not combine
them for obtaining a prediction were excluded.
Type of exposures
Only variables that were collected before hospital dis-
charge were considered as predictors. Glasgow Coma
Scale (GCS) was considered as one predictor variable.
Type of participants
Patients of any age with any type or severity of traumatic
brain injury.
Type of outcome measures
Studies that predict any outcome in traumatic brain injury
patient (i.e. neurological impairment, disability, survival,
etc.). There was no time restriction for the evaluation of
the outcomes.
Search strategy for identification of studies [see Additional 
file 1]
The reference lists of included studies were inspected for
further possible studies meeting the inclusion criteria. A
forward search (citing references in the Web of Knowl-
edge) was conducted with selected seminal papers and
some of the citing papers, not found by the database
search, were inspected for relevance and possible inclu-
sion. All records were converted into an Endnote data-
base.
Trial identification and selection
Two reviewers (PP & PE) independently examined titles,
abstracts and keywords of records from electronic data-
bases, for eligibility. The full text of all potentially relevant
records was obtained and two reviewers (PP & PE) inde-
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pendently assessed whether each met the pre-defined
inclusion criteria. Disagreement was resolved by a third
reviewer (IR).
Quality assessment
Quality assessment scores for controlled clinical trials and
diagnostic studies have been criticized [18,19]. The main
problem with quality scores is to determine the weight
that each item should provide to the overall score. The
abundance of quality scores shows that there is no con-
sensus on this issue. Instead, a component approach
appraisal allows one to evaluate each methodological
aspect. Depending on the question and the study design
some components may be more relevant than others (e.g.
with a surgical intervention blinding of the patient and
caregiver would be unachievable)
In studies of prognostic models in particular, although
diverse quality assessment criteria have been proposed,
there is none widely accepted [14,20-22]. We analyzed the
quality of the prognostic models included in this system-
atic review considering two main domains:
a) Internal validity. This refers to the systematic error of
the study and is related to study design, variables and
analysis strategy.
b) External validity or generalizability. This refers to the
extrapolation of the study to other settings. For making
judgments about generalisability it is important to con-
sider the characteristics of the sample from which the
model was derived, the clear presentation of the results
and finally the model should, ideally, be evaluated (vali-
dated) in a different sample from the original.
Taking into account these two domains,18 questions were
considered for each of the models included [see Addi-
tional file 2].
We restricted the quality assessment to the derivation
studies.
Performance of models externally validated
We reported the performance of models that were vali-
dated in an external sample. We considered as externally
validated those models that were reported by the authors
as evaluated in a different cohort of TBI patients from the
derivation set.
Data extraction
One reviewer (PP) extracted the information from each
study for assessing the quality of reporting in each of the
questions.
Results
A total of 3354 records were identified. After reading all
the records 92 reports were identified and read in full.
Thirty nine were excluded for the following reasons: 18
analyzed individual predictors but did not combine them
in a single score, eight did not include in-hospital predic-
tors, six included patients without traumatic brain injury,
five were not original research (e.g. discussion, letter) and
in two the objective was not to evaluate prognosis in TBI
patients. (Figure 1)
The remaining 53 reports described 102 prognostic mod-
els [see Additional file 3].
General characteristics of the prognostic models [see 
Additional file 4]
Population included
Almost half (47%) of the models were derived from an
adult population, 12% were derived from a child popula-
tion while 21% were derived from a population that
included both adults and children. In 21% of the models
it was not clearly reported from which population they
were derived.
In relation to the severity of the TBI studied, forty five
models (44%) included all grades of severity, thirty one
(30%) included severe TBI, nine (9%) moderate or severe
TBI, nine (9%) mild TBI and in eight (8%) the severity of
TBI was not clearly reported.
Study selection process for the systematic review of prog-nostic models in head inju yFigure 1
Study selection process for the systematic review of prog-
nostic models in head injury.
Reports excluded 
after screening 
abstracts:3262
Total reports identified from 
electronic searches :3354 
Figure 1: Study selection process for the systematic review 
Reports included from electronic search: 
92
Reports excluded with reason (39):
• 18 only analyzed individual predictors 
• 8 did not include in-hospital predictors 
• 6 included patients without TBI 
• 5 were not original research 
• 2 the objective was not to develop or 
evaluate a  prognostic model 
Total of  reports included: 53
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A median of 319 patients (range 22–7764 patients) were
included per model. Three quarters included less than 500
patients.
A total of ninety five models (93%) included populations
from high income countries, five (5%) included popula-
tions from middle income countries and in two (2%) the
population was from a low income country.
Objectives
Most of the models reported (65%), were derived for the
first time (derivation models) while in 35% the models
reported were validating pre-existing models (validation
models). The majority of the validation models (29 out of
35) validated general trauma score. The remaining 6 mod-
els validated specific TBI prognostic score. One validation
model was reported as a letter and information was lim-
ited. Three models validated prognostic scores that were
developed before 1990.
Variables included as predictors
A total of 89 variables were included in the prognostic
models. A mean of 5 variables were included in each
model (range 2 to 13). GCS was the most common pre-
dictor included in the models,(50%) followed by age
(46%) and pupil reactivity (26%). Overall clinical varia-
bles were included in 66% of the models, demographic
variables were included as predictors in 50% of the mod-
els, CT scan predictors were used in 19% of the models
and 7% included variables related to characteristics of the
injury. In 7% of the models other predictors were
included (e.g. other complementary tests or existing
scores).
Outcomes
Mortality was the main outcome in 30% of the models
and GOS in 28%. Other functional outcomes were
reported in 31% of the models. The presence of a CT scan
lesion was the main outcome in 7%, the need of neurosur-
gical intervention in 2% and raised intracranial pressure
in 1%.
Analysis
In the multivariate analysis for the development of prog-
nostic models (n:66) logistic regression was used in 31
(47%) models. Regression tree analysis was reported in 14
(21%) and neural networks in nine (13%). Other meth-
ods of analysis were performed in nine (14%) models
while in one (2%) it was not clear and in three (5%) no
multivariable analysis was performed.
Quality assessment (table 1)
We restricted the quality assessment to the 66 derivation
models. Some of the quality assessment items could only
be applied to logistic regression models.
Internal validity
In over half of the models loss to follow-up was not
reported;15% reported an adequate loss to follow-up (less
than 10%).
Most of the models (68%) did not include a discussion
about the rationale to include the predictors in the model.
A detailed description of the measurement of the predic-
tors was absent in 82% of the models. In one third of the
models the validity of the outcome measures was not
reported.
In relation to the analysis of those that used multivariate
logistic regression, stepwise was the most common
approach (81%). Interactions were examined in 13% of
the models. Predictor variables were analyzed as continu-
ous in 19% of the models. A third (29%) of the models
included at least 10 events per variable analyzed as predic-
tor. The most common strategy to handle missing data
was exclusion of observations (55%).
External Validity
The sample was described in almost all the models (83%).
The procedure to obtain the score was explained in
approximately half of the models (56%), however in
those that used logistic regression only 19% included a
user-friendly presentation.
In relation to the performance of the models, discrimina-
tion was reported in 58% of the models through the area
under the receive operator curve (A.U.R.O.C.), 44% of
which included the respective confidence interval. Cali-
bration was reported with the Homer-Lemeshow test in
27% of the models. Almost half the models(56%)
reported their overall accuracy.
Less than half of the models (38%) were validated, of
which 11% were validated in an external population.
None of the models was evaluated prospectively in a ran-
domized clinical trial to assess the effect in clinical prac-
tice.
Description of externally validated models
Seven models were developed and also reported an exter-
nal validation (table 2). Two other models were valida-
tion of pre-existing models.
Pillai et al. developed a prognostic model to predict unfa-
vourable outcome (death or vegetative state) at one
month [23]. They developed the model in a cohort of 289
patients and validated the model in 26 patients from the
same centre. The predictor variables were oculocephalic
reflex, motor score of the GCS and midline shift score. In
the validation set they reported sensitivity (75%), specifi-
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Table 1: Quality assessment of prognostic models
INTERNAL VALIDITY All models Logistic regression Other analysis
N:66 N:31 N:35
STUDY
Loss to follow-up
< 10% 10 (15%) 5 (16%) 5 (14%)
>10% 19 (29%) 7 (23%) 12 (34%)
Not reported 37 (56%) 19(61%) 18 (52%)
VARIABLES
Discussion about predictors
Yes 21(32%) 11 (35%) 10(29%)
No 45(68%) 20 (65%) 25 (71%)
Description of measurement of predictors
Yes 12 (18%) 8 (26%) 3 (9%)
No 54 (82%) 23(74%) 32 (91%)
Validity of outcome reported
Yes 31 (47%) 14 (45%) 17(49%)
No 20 (30%) 7 (23%) 13 (37%)
Not applicable 15(23%) 10 (32%) 5 (14%)
Handling of missing data
Estimated statistically 4 (6%) 4 (13%) 0
Excluded 36(55%) 16(52%) 20 (57%)
Not reported 26(39%) 11(35%) 15 (43%)
ANALYSIS
Multivariable analysis Stepwise
Backwards - 12 (39%) N/A
Forwards - 3 (10%)
Not specified - 10 (32%)
Not reported - 5 (16%)
Other - 1 (3%)
Interactions examined
Yes - 4 (13%)
Not reported - 27 (87%)
Handling of predictors variables
Continuous - 6 (19%)
Categorical - 16 (52%)
Not clear - 9 (29%)
More than 10 events per variable
Yes - 9 (29%)
No - 16 (52%)
Not reported - 6 (19%)
EXTERNAL VALIDITY All models Logistic regression Other analysis
Description of the sample
Yes 55 (83%) 28 (90%) 27 (77%)
No 11(17%) 3 (10%) 8 (23%)
Presentation of the prognostic model
Normogram 1 (1%) 1 (3%) 0
Simplified score 8 (12%) 4 (13%) 4 (11%)
Figure 13 (20%) 1 (3%) 12 (34%)
Regression formula 15 (23%) 12(39%) 3 (9%)
Not explained 29 (44%) 13(42%) 16 (46%)
EXTERNAL VALIDITY All models Logistic regression Other analysis
N:66 N:31 N:35
Performance reported A.U.C (Discrimination)
Yes - 18 (58%) NA
No - 13(42%)
C.I. presented - 8 out of 18 (44%)
H-L (Calibration)
Yes - 7 (23%) NA
No - 23(74%)
Other - 1 (3%)
Overall accuracy
Yes 37 (56%) 15 (48%) 22 (63%)
No 29 (44%) 16 (52%) 13 (17%)
Validation
Yes 25 (38%) 17 (55%) 8 (23%)
External 7 (11%) 7 (23%) 0
No 41 (62%) 14 (45%) 27 (77%)
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Table 2: Characteristics of models externally validated
Author Derivation sample Validation sample Predictors Outcomes Performance in the 
validation sample
Presentation of a 
simplified score
Pillai et al. 208 patients from India with severe TBI 26 patients from the same centre 1-oculocephalic reflex
2-motor GCS
3-midline shift
Death or vegetative state Sensitivity (75%)
Specificity (67%)
PPV 50%
No
Signorini et al 372 patients from Scotland with 
moderate and severe TBI
520 patients from the same centre 1-GCS
2-ISS
3-pupils reactivity and 
4-haematoma (CT scan)
Survival at 1 year A.U.R.O.C (0.835)
Error rate (15.2%)
Brier score (0.1160)
Hosmer-Lemeshow
(p < 0.001)
Nomogram
Signorini et al 110 patients from Scotland with 
moderate and severe TBI
140 patients from the same centre 1-GCS
2-ISS
3-pupils reactivity and 
4-haematoma (CT scan)
5-ICP measures
Survival at 1 year Not reported No
Hukkelhoven et al. 134 patients from Netherlands with 
moderate and severe TBI
180 patients from the same centre 1-age
2-motor GCS
3-pupils reactivity
4-pupillary size
5-hypotension
6-ISS
Raised ICP A.U.R.O.C. (0.50)
Hosmer-Lemeshow
(p = 0.18)
No
Hukkelhoven et al. 275 patients from Netherlands with 
moderate and severe TBI
250 patients from the same centre 1-age
2-cause of injury
3-pupils reactivity
4-pupillary size
5-hypotension
6-ISS
Surgical removable lesions A.U.R.O.C. (0.67)
Hosmer-Lemeshow
(p = 0.01)
No
Hukkelhoven et al. 2269 patients from 2 trials in high income 
countries with moderate and severe TBI
796 patients from Europe 1-age
2-motorGCS
3-pupils reactivity
4-hypoxia
5-hypotension
6-CT classification
7-subarachnoid haemorrhage
Death or disability at 6 
months
A.U.R.O.C. (0.83)
Hosmer-Lemeshow
(p = 0.05)
Score chart
Hukkelhoven et al. 2269 patients from 2 trials in high income 
countries with moderate and severe TBI
796 patients from Europe and 746 
from the United States
1-age
2-motor GCS
3-pupils reactivity
4-hypoxia
5-hypotension
6-CT classification
7-subarachnoid haemorrhage
Death at 6 months A.U.R.O.C. (0.87/0.89)
Hosmer-Lemeshow
(p = 0.42/<0.001)
Score chart
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city (67%), predictive value of unfavourable outcome
(50%), predictive value of favourable outcome (86%),
percentage of false optimistic results (25%), and percent-
age of false pessimistic results (33%). They did not report
the model's performance measured in the derivation set.
Confidence intervals of the estimates were not reported.
Although the authors reported how to calculate the pre-
diction score, they did not present it in a user-friendly
fashion.
Signorini et al. developed two prognostic models, for one
they used only clinical variables and for the other they
added variables on secondary insults. [24,25] In both
models the outcome was survival at 1 year. The first model
was validated in 520 patients who attended the same cen-
tre. The predictors were age, GCS, ISS, pupils reactivity
and presence of haematoma on the CT scan. They
reported measures of discrimination: A.U.R.O.C. (0.835),
error rate (15.2%) and calibration: brier score (0.1160),
Hosmer-Lemeshow (p < 0.0001). They included a graph
with the 95% confidence interval of the calibration of the
model. The second model was validated in 140 patients
who attended the same centre. The predictor variables
were the same as the first model plus ICP measures.
Although they mentioned that brier score, error rate,
A.U.R.O.C were higher than the original dataset they did
not report the actual estimates. They reported a normo-
gram to predict probability of survival that is user-friendly
for physicians.
Hukkelhoven et al. reported four different models
[26,27]. The outcomes were: raised intracranial pressure
(ICP), surgically removable lesions (SRL), unfavourable
outcome (death, vegetative state or severe disability) and
mortality at six months. For the validation of the first two
outcomes they use an historical (previous) sample of 205
patients from the same centre. The predictors for ICP were
age, motor score, pupil size, pupillary reactivity, hypoten-
sion and ISS. For SRL the predictors were the same except
for motor score which was not, and cause of injury that
was added. For unfavourable outcome they used one data-
base and for mortality two databases, none of these data-
bases were related with the population of the derivation
set. The predictor variables were age, gender, cause of
injury, pupil reactivity, hypotension, hypoxia, CT classifi-
cation and traumatic subarchnoid haemorrhage They
reported the models discrimination: A.U.R.O.C. of 0.50
(95% CI 0.41–0.58), 0.67 (95% CI 0.60–0.75) and 0.83
(95% CI 0.80–0.86) for ICP, SRL, unfavourable outcome
and mortality respectively. They also reported the model
calibration: Hosmer-Lemeshow goodness of fit test of
0.18, 0.01,0.05 and 0.42 (<0.001), for ICP, SRL, unfa-
vourable outcome and mortality respectively (the calibra-
tion of the mortality model was validated in two different
databases). They presented the model as a score chart to
facilitate its use in clinical practice.
Bush et al. validated a model previously developed by the
same group [28]. Their model was intended to allow bet-
ter understanding of factors influencing functional out-
comes and was not intended to predict individual
outcomes. It was not clearly reported whether the patients
came from the same original population. They used path
analysis to evaluate the predictors (functional status,
injury severity and cognitive status) on functional out-
comes (disability rating scale, community integration
questionnaire and return to employment). The reported
difference indexes of goodness of fit that showed that the
originally model fitted better than the validation model.
They did not report any discrimination measures.
Benzer et al. validated a model that used an existing scale,
although they did not provide details of when and how it
was developed [29]. They did not use any kind of multi-
variable analysis. The used a score based in the following
variables : reaction to acoustic stimuli, reaction to pain,
body posture, eye opening, pupil size, pupil response to
light, position and movements of eyeballs and oral
automatisms to predict mortality at 21 days. They did not
report any performance measure, but just the chi square
test for survival of those with low versus high score. They
presented the score in a user-friendly way.
Discussion
This systematic review shows that although publications
of prognostic models for TBI patients are very frequent
their quality is relatively poor. In addition they are rarely
validated on external populations or presented to physi-
cians in a friendly way. Furthermore, only a few are devel-
oped using populations from low and middle income
countries where most trauma occurs.
Patients from all severity spectra were investigated but
prognostic models for moderate and severe TBI patients
were more frequent. It is noteworthy that only 2% of the
models included patients from low income countries tak-
ing into account that 90% of trauma occur in these coun-
tries. Although biologically prognostic factors should be
the same worldwide, is reasonable to consider that the
strength of the association could differ depending on the
medical care received. This difference could affect the
accuracy of the prognostic models in different settings.
Although there is no data about this, an ongoing project
analysing the MRC CRASH Trial Cohort is exploring this
issue.
GCS, age and pupil reactivity were the most common var-
iables analyzed as predictors whereas, G.O.S. and mortal-
ity were the most common outcomes investigated.
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Multiple logistic regression was the multivariable analysis
most frequently used.
We found several limitations in the quality of the models.
The majority did not include a thorough discussion of the
rationale for including the predictor variables. Only a
minority had a loss to follow-up of less than 10%. This is
potentially an important limitation as the loss to follow-
up could be related to prognosis and this could lead to
biased results. Furthermore only four models handle
appropriately the missing data with statistical imputation.
In relation to the multivariable analysis, automatic proce-
dures (stepwise) were quite common in logistic regres-
sion. There is no agreement in relation to the
appropriateness of this strategy. This is shown, for exam-
ple, in conflict recommendations in quality assessment
for prognostic studies; while in one study the use of step-
wise was considered as good quality in other it was con-
sidered as an indicator of a fatal flaw [30]. One of the
limitations we found was that most of the studies did not
explicitly consider clinical criteria to enter the variables in
the model beyond the automatic procedures. Interactions
were hardly ever explored although this is strongly recom-
mended in multivariable analysis [31]. Another common
weakness in the logistic regression models was the lack of
power of the models, as only one third included at least
10 events per variable. It has been proposed that this is the
minimum ratio of events to variables which is large
enough to allow an adequate precision of the estimates
[31].
We did not attempt to obtain an overall quality assess-
ment and instead we evaluated its different components,
this approach makes a cross comparison between differ-
ent analytical strategies difficult because, for example
many of the criteria only apply to logistic regression anal-
ysis.
It is also important to report how well the model works
and for this performance measures should be reported.
Remarkably only two thirds reported a measure of dis-
crimination and only one fifth a measure of calibration.
This is of particular concern considering that calibration is
the most important performance measure for the applica-
tion of the models in clinical practice [32]. Even when a
discrimination measure was reported, less than half pre-
sented confidence intervals to provide readers an estima-
tion of the precision.
For a model to be generalizable to other populations it is
very important to conduct an external validation [32].
Only seven models (three reports) developed and vali-
dated a model but in only one of them the validation was
performed on patients of a different centre. Those models
that considered mortality as an outcome found A.U.R.O.C
that were higher than 0.70 which is considered as excel-
lent discrimination. However the discrimination for the
other outcomes were not as good. Furthermore, the cali-
bration measures were low in all the outcomes consid-
ered.
Finally, to be useful, the method to estimate prognosis
should be clearly reported and, to be clinically practical,
they should be user-friendly. In only half of the models
was it clearly explained how to obtain the prognostic score
and in only one tenth was it reported in such a way that
could be easily applicable in a clinical setting.
From all of the models found in our systematic review we
consider that those developed by Hukkelhoven et al. and
Signorini et al. are the most clinical useful for patients
from high income countries with moderate and severe
TBI, as they fulfilled the majority of the methodological
requirements and showed an acceptable performance in
the external validation, furthermore they are available in
a user-friendly way [27,25].
We acknowledge some limitations in our study. Firstly, we
only included studies that explicitly combined at least two
predictors, in doing so we could have missed some reports
that used multivariable to analyze individual predictors
and did not report in the abstract the overall estimation
although they included the estimate in the full report. Sec-
ondly, we did not include studies that assessed clinical
predictor rules for which although they considered more
than one variable they did not combine them. We consid-
ered that the methodological framework to assess such
studies is fundamentally different from prognostic mod-
els. Thirdly, we restricted our search to 1990 onwards so,
we could have missed some relevant prognostic models
published prior to that date. However because of changes
in management and diagnostic technology in recent years
we doubt that prognostic models previous to 1990 could
be useful for the current medical care of TBI patients.
Finally, another limitation of this paper is that we did not
describe the time of prediction assessment of the prognos-
tic models. Although we acknowledge that this informa-
tion can be clinically very useful unfortunately this data
was seldom available in the reports.
To our knowledge there has been only one previous sys-
tematic review of prognostic models in TBI [17]. They
found 10 reports, all of which were identified in our sys-
tematic review. They validated four of these reports (6
models) in four series of patients. Discrimina-
tion(A.U.R.O.C.) in the validation series ranged from 0.70
to 0.80. On the other hand calibration was poor. They
concluded that large sample sizes and refitting of the orig-
inal model coefficients are related with a better perform-
ance of the models. Unlike ours this systematic review was
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restricted to models that use baseline characteristics to
predict mortality or unfavourable outcome (defined by
G.O.S.) in moderate and severe TBI patients. Furthermore
the search strategy was not specified.
Systematic reviews of prognostic models for other diseases
have found similar results to ours. For example Counsel et
al. conducted a systematic review of prognostic models in
patients with acute stroke [14]. They found 83 prognostic
models but they concluded that none of them has been
sufficiently well developed and validated.
Conclusion
This systematic review describes the limitations of pub-
lished prognostic models in TBI and most importantly
inform researchers who are involved in the development
of prognostic models in TBI. Future studies should con-
sider the following issues to develop valid prognostic
models: thorough discussion with physicians of potential
predictors that are "clinically relevant", clear description
of the measurement and validity of variables included in
the model, large sample size to ensure precise estimates,
adequate handling of continuous variables and missing
data, assessment of interaction in the multivariable analy-
sis, clear description of the calculation of the prognostic
score, external validation and adequate report of model
performance measures, such that physicians can interpret
their accuracy. It should also be encouraged that more
studies include population from low and middle income
countries where most of the burden of TBI occurs. Finally,
for prognostic models to be clinical useful they should be
presented in user-friendly way to be easily applied in the
clinical scenario.
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